These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28119076)

  • 1. Spinal astrocytic c-Jun N-terminal kinase (JNK) activation as counteracting mechanism to the amitriptyline analgesic efficacy in painful peripheral neuropathies.
    Sanna MD; Ghelardini C; Galeotti N
    Eur J Pharmacol; 2017 Mar; 798():85-93. PubMed ID: 28119076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain.
    Mei XP; Zhang H; Wang W; Wei YY; Zhai MZ; Wang W; Xu LX; Li YQ
    J Neuroinflammation; 2011 Jan; 8(1):6. PubMed ID: 21255465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.
    Guo CH; Bai L; Wu HH; Yang J; Cai GH; Wang X; Wu SX; Ma W
    Int J Mol Med; 2016 Nov; 38(5):1433-1442. PubMed ID: 28025994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice.
    Yokai M; Kurihara T; Miyata A
    Mol Pain; 2016; 12():. PubMed ID: 27175011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance.
    Zhuang ZY; Wen YR; Zhang DR; Borsello T; Bonny C; Strichartz GR; Decosterd I; Ji RR
    J Neurosci; 2006 Mar; 26(13):3551-60. PubMed ID: 16571763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.
    Gao YJ; Zhang L; Samad OA; Suter MR; Yasuhiko K; Xu ZZ; Park JY; Lind AL; Ma Q; Ji RR
    J Neurosci; 2009 Apr; 29(13):4096-108. PubMed ID: 19339605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain.
    Tang J; Zhu C; Li ZH; Liu XY; Sun SK; Zhang T; Luo ZJ; Zhang H; Li WY
    J Neuroinflammation; 2015 Mar; 12():57. PubMed ID: 25889689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain.
    Wang W; Mei XP; Wei YY; Zhang MM; Zhang T; Wang W; Xu LX; Wu SX; Li YQ
    Brain Behav Immun; 2011 Oct; 25(7):1355-66. PubMed ID: 21496481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of inhibition of RhoA/Rho kinase signaling in simvastatin-induced amelioration of neuropathic pain.
    Ohsawa M; Ishikura K; Mutoh J; Hisa H
    Neuroscience; 2016 Oct; 333():204-13. PubMed ID: 27457035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of amitriptyline differentially alters neuropathic pain-related behaviour in the presence and absence of a depressive-like phenotype.
    Burke NN; Finn DP; Roche M
    Behav Brain Res; 2015 Feb; 278():193-201. PubMed ID: 25300472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HDAC1/c-JUN complex is essential in the promotion of nerve injury-induced neuropathic pain through JNK signaling.
    Sanna MD; Galeotti N
    Eur J Pharmacol; 2018 Apr; 825():99-106. PubMed ID: 29477655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analgesic effects of β-elemene in rats with neuropathic pain by inhibition of spinal astrocytic ERK activation.
    Ma LT; Bai Y; Cao P; Ren KX; Chen J; Zhang T; Fan BY; Qiao Y; Yan HY; Wang JJ; Li YQ; Zheng J
    Mol Pain; 2022 Apr; 18():17448069221121562. PubMed ID: 35976914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cytochrome P450c17 reduces spinal astrocyte activation in a mouse model of neuropathic pain via regulation of p38 MAPK phosphorylation.
    Choi SR; Beitz AJ; Lee JH
    Biomed Pharmacother; 2019 Oct; 118():109299. PubMed ID: 31387001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of spinal dorsal horn β2-adrenergic receptor ameliorates neuropathic mechanical hypersensitivity through a reduction of phosphorylation of microglial p38 MAP kinase and astrocytic c-jun N-terminal kinase.
    Zhang FF; Morioka N; Abe H; Fujii S; Miyauchi K; Nakamura Y; Hisaoka-Nakashima K; Nakata Y
    Neurochem Int; 2016 Dec; 101():144-155. PubMed ID: 27840124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin exerts antinociceptive effects by inhibiting the activation of astrocytes in spinal dorsal horn and the intracellular extracellular signal-regulated kinase signaling pathway in rat model of chronic constriction injury.
    Ji FT; Liang JJ; Liu L; Cao MH; Li F
    Chin Med J (Engl); 2013 Mar; 126(6):1125-31. PubMed ID: 23506591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the spinal BDNF-activated JNK pathway prevents the development of antiretroviral-induced neuropathic pain.
    Sanna MD; Ghelardini C; Galeotti N
    Neuropharmacology; 2016 Jun; 105():543-552. PubMed ID: 26898292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intrathecal injection of rapamycin on pain threshold and spinal cord glial activation in rats with neuropathic pain.
    Lv J; Li Z; She S; Xu L; Ying Y
    Neurol Res; 2015 Aug; 37(8):739-43. PubMed ID: 26004146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nitroxyl donor, Angeli's salt, reduces chronic constriction injury-induced neuropathic pain.
    Longhi-Balbinot DT; Rossaneis AC; Pinho-Ribeiro FA; Bertozzi MM; Cunha FQ; Alves-Filho JC; Cunha TM; Peron JP; Miranda KM; Casagrande R; Verri WA
    Chem Biol Interact; 2016 Aug; 256():1-8. PubMed ID: 27287419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice.
    Guida F; Lattanzi R; Boccella S; Maftei D; Romano R; Marconi V; Balboni G; Salvadori S; Scafuro MA; de Novellis V; Negri L; Maione S; Luongo L
    Pharmacol Res; 2015 Jan; 91():36-46. PubMed ID: 25434589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.
    Jeon S; Jha MK; Ock J; Seo J; Jin M; Cho H; Lee WH; Suk K
    J Biol Chem; 2013 Aug; 288(33):24116-27. PubMed ID: 23836894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.